Nvidia’s $100 Billion OpenAI Investment Faces Internal Doubts, Report Says 
BOJ Policymakers Warn Weak Yen Could Fuel Inflation Risks and Delay Rate Action 
Japan Election Poll Signals Landslide Win for Sanae Takaichi, Raising Fiscal Policy Concerns 
Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees 
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations 
Why Trump’s new pick for Fed chair hit gold and silver markets – for good reasons 
U.S. Eases Venezuela Oil Sanctions to Boost American Investment After Maduro Ouster 
Hyundai Motor Lets Russia Plant Buyback Option Expire Amid Ongoing Ukraine War 
U.S. Government Faces Brief Shutdown as Congress Delays Funding Deal 
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand 
Wall Street Slips as Tech Stocks Slide on AI Spending Fears and Earnings Concerns 
UK Employers Plan Moderate Pay Rises as Inflation Pressures Ease but Persist 
U.S.–Venezuela Relations Show Signs of Thaw as Top Envoy Visits Caracas 
Gold and Silver Prices Plunge as Trump Taps Kevin Warsh for Fed Chair 
China Factory Activity Slips in January as Weak Demand Weighs on Growth Outlook 
Starmer’s China Visit Highlights Western Balancing Act Amid U.S.-China Rivalry 
Asian Stocks Waver as Trump Signals Fed Pick, Shutdown Deal and Tech Earnings Stir Markets 
SK C&C has signed a deal with Microsoft Korea for cooperation in the advancement of AI cerebral hemorrhage solutions. The former is planning to register its imaging solution on Microsoft Azure for its healthcare platform.
SK C&C said it inked the memorandum of understanding (MOU) with Microsoft Korea on Thursday, Feb. 2. It has partnered with the American tech firm so it can expand into the global market for digital healthcare solutions. The IT services unit of the SK Group is also aiming to strengthen the industry ecosystem through the deal.
As per The Korea Economic Daily, under the agreement, the Medical Insight Plus Cerebral Hemorrhage imaging medical solution that was developed by SK C&C will be filed under the Microsoft Azure Healthcare neuroradiology category which is the company's cloud platform that specializes in healthcare.
Once registered, medical clinics that would like to make use of the solution can simply buy it from the Azure Marketplace. Buyers will also be able to receive follow-up services on the platform. SK C&C will also jump into the global market by working with the in-country sales organization of Microsoft company.
"Starting with Asia and Oceania, we will actively seek out various solutions for the global healthcare market as well as customized digital IT service markets in the medical field," SK C&C's Healthcare Group's head, Yoon Dong Joon, said.
Korea Biomed Review stated that SK C&C's Medical Insight+ Brain Hemorrhage is an AI-based cerebral hemorrhage imaging solution that assesses brain CT scan images. The solution can complete the analysis within seconds. Thus, doctors are immediately informed about any bleeding or abnormalities detected. The company said that the accuracy of the software is more than 98%
SK C&C further stressed that the imaging solution software has the ability to identify even the smallest bleeding that can be missed by professional neuro-head and neck radiologists.
